Search
forResearch 10 of 1000+
- High-resolution mass spectrometric investigation of the phase I and II metabolites of finasteride in pig plasma, urine and bile
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- Protective Activity against Oxidative Stress in Dermal Papillae with Extracted Herbal Essential Oils
- Chapter 14 Principles of drug metabolism
- The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
- [Drug induced alopecia].
- Estradiol protects hair cells from cisplatin-induced ototoxicity via Nrf2 activation
- 1316 Aqueous extract of Mentha suaveolens induces Nrf-2 activation and expression of antioxidant and detoxifying enzymes in human keratinocyte HaCaT
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
Learn 1 of 27
All learn results →Community 10 of 420
- Phase II topical dut study - outperforms oral fin with a minor DHT reduction
- GT20029 phase II results release date?
- About Pyrilutamide Phase II US Trial
- KX-826 1% Phase II Results from China Just Dropped
- KX-826 Phase II Results Just Dropped (Male AGA) – Key Takeaways
- GT20029 - Promising phase II results
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- Where are GT20029 phase II results?
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- So why did the first pyrilutamide phase III fail?